title: Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort.
abstract: Asplenic patients have a lifelong risk of overwhelming post-splenectomy infection and have been reported to have low numbers of peripheral blood IgM memory B cells. The clinical value of quantitation of memory B cells as an indicator of splenic abnormality or risk of infection has been unclear. To assess changes in B cell sub-populations after splenectomy we studied patients recruited to a spleen registry (n = 591). A subset of 209 adult asplenic or hyposplenic subjects, and normal controls (n = 140) were tested for IgM memory B cells. We also determined a) changes in IgM memory B cells with time after splenectomy using the cross-sectional data from patients on the registry and b) the kinetics of changes in haematological markers associated with splenectomy(n = 45). Total B cells in splenectomy patients did not differ from controls, but memory B cells, IgM memory B cells and switched B cells were significantly (p<0.001) reduced. The reduction was similar for different indications for splenectomy. Changes of asplenia in routine blood films including presence of Howell-Jolly bodies (HJB), occurred early (median 25 days) and splenectomy associated thrombocytosis and lymphocytosis peaked by 50 days. There was a more gradual decrease in IgM memory B cells reaching a stable level within 6 months after splenectomy. IgM memory B cells as proportion of B cells was the best discriminator between splenectomized patients and normal controls and at the optimal cut-off of 4.53, showed a true positive rate of 95% and false positive rate of 20%. In a survey of 152 registry patients stratified by IgM memory B cells around this cut-off there was no association with minor infections and no registry patients experienced OPSI during the study. Despite significant changes after splenectomy, conventional measures of IgM memory cells have limited clinical utility in this population.
authors.affiliation: Pathology Services, The Alfred Hospital, Melbourne, Victoria, Australia. Paul.U.Cameron@monash.edu
authors.forename: Paul U
authors.initials: PU
authors.lastname: Cameron
authors.forename: Penelope
authors.initials: P
authors.lastname: Jones
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Gorniak
authors.forename: Kate
authors.initials: K
authors.lastname: Dunster
authors.forename: Eldho
authors.initials: E
authors.lastname: Paul
authors.forename: Sharon
authors.initials: S
authors.lastname: Lewin
authors.forename: Ian
authors.initials: I
authors.lastname: Woolley
authors.forename: Denis
authors.initials: D
authors.lastname: Spelman
mesh_terms: D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology*; D002453:Cell Cycle; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology*; D007156:Immunologic Memory; D012042:Registries; D013156:Splenectomy
chemical_list: D007075:Immunoglobulin M